Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-21-000181
Filing Date
2021-05-17
Accepted
2021-05-17 12:19:12
Documents
26
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q skin0514form10q.htm 10-Q 137170
2 EXHIBIT 31.1 skin0514form10qexh31_1.htm EX-31.1 8264
3 EXHIBIT 31.2 skin0514form10qexh31_2.htm EX-31.2 8283
4 EXHIBIT 32.1 skin0514form10qexh32_1.htm EX-32.1 4122
  Complete submission text file 0001554795-21-000181.txt   689182

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE skin-20210331.xml EX-101.INS 37576
6 XBRL SCHEMA FILE skin-20210331.xsd EX-101.SCH 7712
7 XBRL CALCULATION FILE skin-20210331_cal.xml EX-101.CAL 15930
8 XBRL DEFINITION FILE skin-20210331_def.xml EX-101.DEF 9703
9 XBRL LABEL FILE skin-20210331_lab.xml EX-101.LAB 71497
10 XBRL PRESENTATION FILE skin-20210331_pre.xml EX-101.PRE 51463
Mailing Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106 8013232395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

EIN.: 870458170 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30991 | Film No.: 21928889
SIC: 6770 Blank Checks